| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2851333 | American Heart Journal | 2009 | 9 Pages |
Abstract
Granulocyte macrophage colony-stimulating factor therapy in patients with PAD was associated with mobilization of progenitor cells, improvement of endothelial dysfunction, and exercise capacity. The efficacy of strategies designed to mobilize bone marrow progenitors warrants further study in patients with PAD.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Veerappan MD, Edmund K. MD, PhD, Jonathan R. MD, Amita PhD, Sagar MD, Karthikeswar MD, Diane BS, Wayne BS, W. Robert MD, PhD, FACC, R. Wayne MD, PhD, FACC, Arshed A. MD, FACC,